MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on December 19, 2007; DOI: 10.1124/mol.107.041210


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
mol.107.041210v1
73/5/1444    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bauer, B.
Right arrow Articles by Potschka, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bauer, B.
Right arrow Articles by Potschka, H.


Received for publication August 27, 2007.
Revised December 19, 2007.
Accepted for publication December 19, 2007.

Seizure-Induced Upregulation of P-glycoprotein at the Blood-Brain Barrier through Glutamate and COX-2 Signaling

Bjoern Bauer 1, Anika M.S. Hartz 1, Anton Pekcec 2, Kathrin Toellner 3, David S. Miller 4, Heidrun Potschka 2*

1 NIEHS/NIH & University of Minnesota 2 Ludwig-Maximilians-University Munich 3 University of Veterinary Medicine Hannover 4 NIEHS/NIH

* Address correspondence to: E-mail: potschka{at}pharmtox.vetmed.uni-muenchen.de

Abstract

Increased expression of drug efflux transporters at the blood-brain barrier accompanies epileptic seizures and complicates therapy with antiepileptic drugs. The present study is concerned with identifying mechanistic links that connect seizure activity to increased P-glycoprotein expression at the blood-brain barrier. In this regard, we tested the hypothesis that seizures increase brain extracellular glutamate, which signals through an NMDA receptor and COX-2 in brain capillaries to increase blood-brain barrier P-glycoprotein expression. Consistent with this hypothesis, exposing isolated rat or mouse brain capillaries to glutamate for 15-30 min increased P-glycoprotein expression and transport activity hours later. These increases were blocked by MK-801, an NMDA receptor antagonist, and by celecoxib, a selective COX-2 inhibitor; no such glutamate-induced increases were seen in brain capillaries from COX-2-null mice. In rats, intracerebral microinjection of glutamate caused locally increased P-glycoprotein expression in brain capillaries. Moreover, using a pilocarpine status epilepticus rat model, we observed seizure-induced increases in capillary P-glycoprotein expression that were attenuated by administration of indomethacin, a COX inhibitor. Our findings suggest that brain uptake of some antiepileptic drugs can be enhanced through COX-2 inhibition. Moreover, they provide insight into one mechanism that underlies drug resistance in epilepsy and possibly other CNS disorders.


Key words: Glutamate, MDR/p-Glycoprotein, Cyclooxygenases


This article has been cited by other articles:


Home page
Pharmacol. Rev.Home page
D. S. Miller, B. Bauer, and A. M. S. Hartz
Modulation of P-Glycoprotein at the Blood-Brain Barrier: Opportunities to Improve Central Nervous System Pharmacotherapy
Pharmacol. Rev., June 1, 2008; 60(2): 196 - 209.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2007 by the American Society for Pharmacology and Experimental Therapeutics